Assignee profile:

deCODE Genetics ehf.

City:

Reykjavik

Country:

Iceland

Published Applications:

82

Last publication date:

2014-09-18

Patent Grants:

36

Last grant date:

2014-08-05

Top Inventors for applications by deCODE Genetics ehf.

These are the the leading inventors for applications assigned to deCODE Genetics ehf.:

Recent patent applications by deCODE Genetics ehf.

deCODE Genetics ehf. based in Reykjavik, IS has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-09-18
US20140275553A1
Chemistry; metallurgy

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#2 | 2014-09-04
US20140248615A1
Chemistry; metallurgy

GENETIC VARIANTS ON CHR 11Q AND 6Q AS MARKERS FOR PROSTATE AND COLORECTAL CANCER PREDISPOSITION

#3 | 2014-08-14
US20140227693A1
Chemistry; metallurgy

GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND STROKE

#4 | 2014-06-26
US20140179546A1
Chemistry; metallurgy

GENETIC VARIANTS ON CHR 5P12 AND 10Q26 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT

#5 | 2014-03-27
US20140087961A1
Chemistry; metallurgy

GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCER

#6 | 2014-03-20
US20140080727A1
Chemistry; metallurgy

VARIANTS PREDICTIVE OF RISK OF GOUT

#7 | 2013-12-19
US20130338012A1
Chemistry; metallurgy

GENETIC RISK FACTORS OF SICK SINUS SYNDROME

#8 | 2013-11-07
US20130296175A1
Chemistry; metallurgy

Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment

#9 | 2013-10-17
US20130273543A1
Chemistry; metallurgy

GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCER

#10 | 2013-09-26
US20130253847A1
Physics

GENETIC VARIANTS AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EOSINOPHILIA, ASTHMA, AND MYOCARDIAL INFARCTION

#11 | 2013-08-29
US20130224739A1
Chemistry; metallurgy

GENETIC MARKERS FOR RISK MANAGEMENT OF VASCULAR DISEASE

#12 | 2012-10-18
US20120264636A1
Chemistry; metallurgy

GENETIC VARIANTS INDICATIVE OF VASCULAR CONDITIONS

#13 | 2012-08-30 βœ… Patent 8,796,182 granted on 2014-08-05
US20120220477A1
Chemistry; metallurgy

Genetic markers associated with risk of diabetes mellitus

#14 | 2012-08-16
US20120208709A1
Chemistry; metallurgy

GENETIC SUSCEPTIBILITY VARIANTS ASSOCIATED WITH CARDIOVASCULAR DISEASE

#15 | 2012-08-16
US20120207729A1
Chemistry; metallurgy

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#16 | 2012-07-19 βœ… Patent 8,791,267 granted on 2014-07-29
US20120183522A1
Chemistry; metallurgy

Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

#17 | 2012-06-14
US20120149016A1
Chemistry; metallurgy

Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes Mellitus

#18 | 2012-05-17
US20120122698A1
Chemistry; metallurgy

Genetic Variants Predictive of Cancer Risk in Humans

#19 | 2012-01-26 βœ… Patent 8,795,963 granted on 2014-08-05
US20120021989A1
Chemistry; metallurgy

Genetic markers for risk management of atrial fibrillation and stroke

#20 | 2011-12-01 βœ… Patent 8,951,735 granted on 2015-02-10
US20110294673A1
Chemistry; metallurgy

Genetic variants for breast cancer risk assessment

#21 | 2011-11-24
US20110287946A1
Chemistry; metallurgy

Genetic Variants Useful for Risk Assessment of Thyroid Cancer

#22 | 2011-11-03
US20110269143A1
Chemistry; metallurgy

Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment

#23 | 2011-10-27 βœ… Patent 8,808,985 granted on 2014-08-19
US20110262901A1
Chemistry; metallurgy

Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm

#24 | 2011-09-22
US20110230366A1
Chemistry; metallurgy

Genetic Variants Useful for Risk Assessment of Thyroid Cancer

#25 | 2011-09-01
US20110212855A1
Chemistry; metallurgy

Genetic Variants Predictive of Cancer Risk

#26 | 2011-05-19
US20110117545A1
Chemistry; metallurgy

GENETIC VARIANTS ON CHR2 AND CHR16 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT

#27 | 2011-04-21 βœ… Patent 8,828,657 granted on 2014-09-09
US20110091880A1
Chemistry; metallurgy

Susceptibility variants for lung cancer

#28 | 2011-03-03 βœ… Patent 8,697,360 granted on 2014-04-15
US20110053281A1
Physics

Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition

#29 | 2011-01-27
US20110020320A1
Chemistry; metallurgy

Genetic Variants Contributing to Risk of Prostate Cancer

#30 | 2011-01-20 βœ… Patent 8,580,501 granted on 2013-11-12
US20110015081A1
Chemistry; metallurgy

Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment

#31 | 2010-08-26
US20100216863A1
Human necessities

Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment

#32 | 2010-06-24 βœ… Patent 8,367,333 granted on 2013-02-05
US20100160802A1
Chemistry; metallurgy

Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction

#33 | 2010-05-27
US20100129799A1
Chemistry; metallurgy

CANCER SUSCEPTIBILITY VARIANTS ON CHR8Q24.21

#34 | 2010-05-13
US20100120045A1
Chemistry; metallurgy

GENETIC VARIANTS USEFUL FOR RISK ASSESSMENTS OF CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION

#35 | 2010-03-18 βœ… Patent 9,617,597 granted on 2017-04-11
US20100068705A1
Chemistry; metallurgy

Genetic susceptibility variants associated with cardiovascular disease

#36 | 2010-02-25
US20100047807A1
Chemistry; metallurgy

GENETIC VARIANTS ASSOCIATED WITH PERIODIC LIMB MOVEMENTS AND RESTLESS LEGS SYNDROME

#37 | 2009-12-31 βœ… Patent 8,637,244 granted on 2014-01-28
US20090325163A1
Chemistry; metallurgy

Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke

#38 | 2009-12-31
US20090324569A1
Chemistry; metallurgy

BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS

#39 | 2009-12-24
US20090317799A1
Chemistry; metallurgy

Variants at chr8q24.21 confer risk of cancer

#40 | 2009-11-26
US20090291948A1
Chemistry; metallurgy

SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE

#41 | 2009-11-05
US20090275043A1
Chemistry; metallurgy

Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus

#42 | 2009-09-17
US20090233969A1
Chemistry; metallurgy

BIARYL SUBSTITUTED NITROGEN CONTAINING HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION

#43 | 2009-06-25 βœ… Patent 8,598,359 granted on 2013-12-03
US20090163462A1
Chemistry; metallurgy

Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation

#44 | 2009-05-28
US20090136473A1
Chemistry; metallurgy

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#45 | 2009-05-21 βœ… Patent 8,877,816 granted on 2014-11-04
US20090131530A1
Chemistry; metallurgy

4-(or 5-) substituted catechol derivatives

#46 | 2009-05-21 βœ… Patent 8,883,833 granted on 2014-11-11
US20090130077A1
Chemistry; metallurgy

Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

#47 | 2009-05-21
US20090130076A1
Chemistry; metallurgy

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#48 | 2009-01-29
US20090030037A1
Human necessities

Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy

#49 | 2008-10-23 βœ… Patent 7,495,147 granted on 2009-02-24
US20080263690A1
Chemistry; metallurgy

Neuregulin-1 transgenic mouse and methods of use

#50 | 2008-06-10 βœ… Patent 7,384,736 granted on 2008-06-10
US9947991
-

Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease

#51 | 2008-05-29
US20080125477A1
Human necessities

7-(ACRYLOYL) INDOLE COMPOSITIONS AND METHODS OF MAKING AND USING SAME

#52 | 2008-04-17 βœ… Patent 7,728,032 granted on 2010-06-01
US20080090839A1
Chemistry; metallurgy

Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation

#53 | 2008-02-07 βœ… Patent 7,989,480 granted on 2011-08-02
US20080033024A1
Chemistry; metallurgy

Aryl amino acid derivatives as inhibitors for treating inflammation

#54 | 2008-02-07 βœ… Patent 8,115,005 granted on 2012-02-14
US20080033013A1
Chemistry; metallurgy

Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation

#55 | 2008-01-03
US20080003598A1
Chemistry; metallurgy

Association of gene expression and psychiatric disoders

#56 | 2007-12-06 βœ… Patent 8,158,362 granted on 2012-04-17
US20070280917A1
Chemistry; metallurgy

Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype

#57 | 2007-11-29 βœ… Patent 7,435,548 granted on 2008-10-14
US20070275406A1
Physics

Methods for producing ex vivo models for inflammatory disease and uses thereof

#58 | 2007-11-22 βœ… Patent 7,579,483 granted on 2009-08-25
US20070270594A1
Chemistry; metallurgy

Process for preparing 7-(acryloyl)indoles

#59 | 2007-06-28 βœ… Patent 7,750,012 granted on 2010-07-06
US20070149544A1
Chemistry; metallurgy

Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation

#60 | 2007-06-21 βœ… Patent 7,674,802 granted on 2010-03-09
US20070142434A1
Chemistry; metallurgy

N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation

#61 | 2007-06-21 βœ… Patent 7,576,102 granted on 2009-08-18
US20070142432A1
Chemistry; metallurgy

Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation

#62 | 2006-12-21 βœ… Patent 7,585,630 granted on 2009-09-08
US20060286588A1
Chemistry; metallurgy

Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus

#63 | 2006-12-19 βœ… Patent 7,152,073 granted on 2006-12-19
US10603112
-

Method and system for defining sets by querying relational data using a set definition language

#64 | 2006-12-12 βœ… Patent 7,148,008 granted on 2006-12-12
US10234652
-

Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease

#65 | 2006-11-16
US20060257481A1
Human necessities

Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy

#66 | 2006-10-03 βœ… Patent 7,115,586 granted on 2006-10-03
US10272936
-

Non-inclusion cyclodextrin complexes

#67 | 2006-04-13 βœ… Patent 7,598,397 granted on 2009-10-06
US20060079520A1
Chemistry; metallurgy

Sulfonamide peri-substituted bicyclics for occlusive artery disease

#68 | 2006-03-21 βœ… Patent 7,016,910 granted on 2006-03-21
US10316986
-

Indexing, rewriting and efficient querying of relations referencing semistructured data

#69 | 2006-01-19
US20060014165A1
Chemistry; metallurgy

Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association

#70 | 2005-12-29
US20050287551A1
Chemistry; metallurgy

Susceptibility gene for human stroke; methods of treatment

#71 | 2005-12-22
US20050282855A1
Human necessities

Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment

#72 | 2005-12-08
US20050272051A1
Human necessities

Methods of preventing or treating recurrence of myocardial infarction

#73 | 2005-09-29
US20050214780A1
Chemistry; metallurgy

Human type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5

#74 | 2005-09-22
US20050208527A1
Chemistry; metallurgy

Human schizophrenia gene

#75 | 2005-09-08
US20050196784A1
Chemistry; metallurgy

Human Type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5

#76 | 2005-09-01 βœ… Patent 7,244,571 granted on 2007-07-17
US20050191272A1
Physics

Methods for producing Ex vivo models for inflammatory disease and uses thereof

#77 | 2005-07-28
US20050164220A1
Chemistry; metallurgy

Susceptibility gene for human stroke: method of treatment

#78 | 2005-05-26 βœ… Patent 7,851,486 granted on 2010-12-14
US20050113408A1
Chemistry; metallurgy

Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment

#79 | 2005-05-26 βœ… Patent 7,507,531 granted on 2009-03-24
US20050112611A1
Chemistry; metallurgy

Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction

#80 | 2005-05-24 βœ… Patent 6,897,027 granted on 2005-05-24
US10109587
-

Method for desalting nucleic acids

#81 | 2005-05-17 βœ… Patent 6,893,828 granted on 2005-05-17
US9947954
-

Methods for producing ex vivo models for inflammatory disease and uses thereof

#82 | 2005-03-03
US20050050030A1
Physics

Set definition language for relational data

AssigneeID:

36971 ⎘